Global Life Science CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Life Science CDMO market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Life Science CDMO industry chain, the market status of Pharmaceutical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), Clinical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Life Science CDMO.
Regionally, the report analyzes the Life Science CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Life Science CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Life Science CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Life Science CDMO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Life Science CDMO market.
Regional Analysis: The report involves examining the Life Science CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Life Science CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Life Science CDMO:
Company Analysis: Report covers individual Life Science CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Life Science CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Clinical).
Technology Analysis: Report covers specific technologies relevant to Life Science CDMO. It assesses the current state, advancements, and potential future developments in Life Science CDMO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Life Science CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Life Science CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Life Science CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Life Science CDMO, with revenue, gross margin and global market share of Life Science CDMO from 2019 to 2024.
Chapter 3, the Life Science CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Life Science CDMO market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Life Science CDMO.
Chapter 13, to describe Life Science CDMO research findings and conclusion.
The Global Info Research report includes an overview of the development of the Life Science CDMO industry chain, the market status of Pharmaceutical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), Clinical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Life Science CDMO.
Regionally, the report analyzes the Life Science CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Life Science CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Life Science CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Life Science CDMO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Life Science CDMO market.
Regional Analysis: The report involves examining the Life Science CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Life Science CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Life Science CDMO:
Company Analysis: Report covers individual Life Science CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Life Science CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Clinical).
Technology Analysis: Report covers specific technologies relevant to Life Science CDMO. It assesses the current state, advancements, and potential future developments in Life Science CDMO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Life Science CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Life Science CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Active Pharmaceutical Ingredient (API) CDMO
- Biologics CDMO
- Finished Dosage Form (FDF) CDMO
- Others
- Pharmaceutical
- Clinical
- Research
- Lonza Group
- Thermo Fisher Scientific
- Catalent
- WuXi Biologics
- Samsung Biologics
- Siegfried
- Fujifilm Diosynth Biotechnologies
- Lars Petersen
- Recipharm
- Boehringer Ingelheim
- MilliporeSigma
- Aenova Group
- AGC Parma Chemicals
- GenScript
- Novartis
- Sai Life Sciences
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Life Science CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Life Science CDMO, with revenue, gross margin and global market share of Life Science CDMO from 2019 to 2024.
Chapter 3, the Life Science CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Life Science CDMO market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Life Science CDMO.
Chapter 13, to describe Life Science CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Life Science CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Life Science CDMO by Type
1.3.1 Overview: Global Life Science CDMO Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Life Science CDMO Consumption Value Market Share by Type in 2023
1.3.3 Active Pharmaceutical Ingredient (API) CDMO
1.3.4 Biologics CDMO
1.3.5 Finished Dosage Form (FDF) CDMO
1.3.6 Others
1.4 Global Life Science CDMO Market by Application
1.4.1 Overview: Global Life Science CDMO Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Clinical
1.4.4 Research
1.5 Global Life Science CDMO Market Size & Forecast
1.6 Global Life Science CDMO Market Size and Forecast by Region
1.6.1 Global Life Science CDMO Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Life Science CDMO Market Size by Region, (2019-2030)
1.6.3 North America Life Science CDMO Market Size and Prospect (2019-2030)
1.6.4 Europe Life Science CDMO Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Life Science CDMO Market Size and Prospect (2019-2030)
1.6.6 South America Life Science CDMO Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Life Science CDMO Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Life Science CDMO Product and Solutions
2.1.4 Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Life Science CDMO Product and Solutions
2.2.4 Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Life Science CDMO Product and Solutions
2.3.4 Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Catalent Recent Developments and Future Plans
2.4 WuXi Biologics
2.4.1 WuXi Biologics Details
2.4.2 WuXi Biologics Major Business
2.4.3 WuXi Biologics Life Science CDMO Product and Solutions
2.4.4 WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 WuXi Biologics Recent Developments and Future Plans
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business
2.5.3 Samsung Biologics Life Science CDMO Product and Solutions
2.5.4 Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Samsung Biologics Recent Developments and Future Plans
2.6 Siegfried
2.6.1 Siegfried Details
2.6.2 Siegfried Major Business
2.6.3 Siegfried Life Science CDMO Product and Solutions
2.6.4 Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Siegfried Recent Developments and Future Plans
2.7 Fujifilm Diosynth Biotechnologies
2.7.1 Fujifilm Diosynth Biotechnologies Details
2.7.2 Fujifilm Diosynth Biotechnologies Major Business
2.7.3 Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Solutions
2.7.4 Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
2.8 Lars Petersen
2.8.1 Lars Petersen Details
2.8.2 Lars Petersen Major Business
2.8.3 Lars Petersen Life Science CDMO Product and Solutions
2.8.4 Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lars Petersen Recent Developments and Future Plans
2.9 Recipharm
2.9.1 Recipharm Details
2.9.2 Recipharm Major Business
2.9.3 Recipharm Life Science CDMO Product and Solutions
2.9.4 Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Recipharm Recent Developments and Future Plans
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business
2.10.3 Boehringer Ingelheim Life Science CDMO Product and Solutions
2.10.4 Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Boehringer Ingelheim Recent Developments and Future Plans
2.11 MilliporeSigma
2.11.1 MilliporeSigma Details
2.11.2 MilliporeSigma Major Business
2.11.3 MilliporeSigma Life Science CDMO Product and Solutions
2.11.4 MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MilliporeSigma Recent Developments and Future Plans
2.12 Aenova Group
2.12.1 Aenova Group Details
2.12.2 Aenova Group Major Business
2.12.3 Aenova Group Life Science CDMO Product and Solutions
2.12.4 Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aenova Group Recent Developments and Future Plans
2.13 AGC Parma Chemicals
2.13.1 AGC Parma Chemicals Details
2.13.2 AGC Parma Chemicals Major Business
2.13.3 AGC Parma Chemicals Life Science CDMO Product and Solutions
2.13.4 AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 AGC Parma Chemicals Recent Developments and Future Plans
2.14 GenScript
2.14.1 GenScript Details
2.14.2 GenScript Major Business
2.14.3 GenScript Life Science CDMO Product and Solutions
2.14.4 GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GenScript Recent Developments and Future Plans
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Life Science CDMO Product and Solutions
2.15.4 Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Novartis Recent Developments and Future Plans
2.16 Sai Life Sciences
2.16.1 Sai Life Sciences Details
2.16.2 Sai Life Sciences Major Business
2.16.3 Sai Life Sciences Life Science CDMO Product and Solutions
2.16.4 Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sai Life Sciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Life Science CDMO Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Life Science CDMO by Company Revenue
3.2.2 Top 3 Life Science CDMO Players Market Share in 2023
3.2.3 Top 6 Life Science CDMO Players Market Share in 2023
3.3 Life Science CDMO Market: Overall Company Footprint Analysis
3.3.1 Life Science CDMO Market: Region Footprint
3.3.2 Life Science CDMO Market: Company Product Type Footprint
3.3.3 Life Science CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Life Science CDMO Consumption Value and Market Share by Type (2019-2024)
4.2 Global Life Science CDMO Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Life Science CDMO Consumption Value Market Share by Application (2019-2024)
5.2 Global Life Science CDMO Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Life Science CDMO Consumption Value by Type (2019-2030)
6.2 North America Life Science CDMO Consumption Value by Application (2019-2030)
6.3 North America Life Science CDMO Market Size by Country
6.3.1 North America Life Science CDMO Consumption Value by Country (2019-2030)
6.3.2 United States Life Science CDMO Market Size and Forecast (2019-2030)
6.3.3 Canada Life Science CDMO Market Size and Forecast (2019-2030)
6.3.4 Mexico Life Science CDMO Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Life Science CDMO Consumption Value by Type (2019-2030)
7.2 Europe Life Science CDMO Consumption Value by Application (2019-2030)
7.3 Europe Life Science CDMO Market Size by Country
7.3.1 Europe Life Science CDMO Consumption Value by Country (2019-2030)
7.3.2 Germany Life Science CDMO Market Size and Forecast (2019-2030)
7.3.3 France Life Science CDMO Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Life Science CDMO Market Size and Forecast (2019-2030)
7.3.5 Russia Life Science CDMO Market Size and Forecast (2019-2030)
7.3.6 Italy Life Science CDMO Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Life Science CDMO Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Life Science CDMO Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Life Science CDMO Market Size by Region
8.3.1 Asia-Pacific Life Science CDMO Consumption Value by Region (2019-2030)
8.3.2 China Life Science CDMO Market Size and Forecast (2019-2030)
8.3.3 Japan Life Science CDMO Market Size and Forecast (2019-2030)
8.3.4 South Korea Life Science CDMO Market Size and Forecast (2019-2030)
8.3.5 India Life Science CDMO Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Life Science CDMO Market Size and Forecast (2019-2030)
8.3.7 Australia Life Science CDMO Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Life Science CDMO Consumption Value by Type (2019-2030)
9.2 South America Life Science CDMO Consumption Value by Application (2019-2030)
9.3 South America Life Science CDMO Market Size by Country
9.3.1 South America Life Science CDMO Consumption Value by Country (2019-2030)
9.3.2 Brazil Life Science CDMO Market Size and Forecast (2019-2030)
9.3.3 Argentina Life Science CDMO Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Life Science CDMO Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Life Science CDMO Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Life Science CDMO Market Size by Country
10.3.1 Middle East & Africa Life Science CDMO Consumption Value by Country (2019-2030)
10.3.2 Turkey Life Science CDMO Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Life Science CDMO Market Size and Forecast (2019-2030)
10.3.4 UAE Life Science CDMO Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Life Science CDMO Market Drivers
11.2 Life Science CDMO Market Restraints
11.3 Life Science CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Life Science CDMO Industry Chain
12.2 Life Science CDMO Upstream Analysis
12.3 Life Science CDMO Midstream Analysis
12.4 Life Science CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Life Science CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Life Science CDMO by Type
1.3.1 Overview: Global Life Science CDMO Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Life Science CDMO Consumption Value Market Share by Type in 2023
1.3.3 Active Pharmaceutical Ingredient (API) CDMO
1.3.4 Biologics CDMO
1.3.5 Finished Dosage Form (FDF) CDMO
1.3.6 Others
1.4 Global Life Science CDMO Market by Application
1.4.1 Overview: Global Life Science CDMO Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Clinical
1.4.4 Research
1.5 Global Life Science CDMO Market Size & Forecast
1.6 Global Life Science CDMO Market Size and Forecast by Region
1.6.1 Global Life Science CDMO Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Life Science CDMO Market Size by Region, (2019-2030)
1.6.3 North America Life Science CDMO Market Size and Prospect (2019-2030)
1.6.4 Europe Life Science CDMO Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Life Science CDMO Market Size and Prospect (2019-2030)
1.6.6 South America Life Science CDMO Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Life Science CDMO Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Life Science CDMO Product and Solutions
2.1.4 Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Life Science CDMO Product and Solutions
2.2.4 Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Life Science CDMO Product and Solutions
2.3.4 Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Catalent Recent Developments and Future Plans
2.4 WuXi Biologics
2.4.1 WuXi Biologics Details
2.4.2 WuXi Biologics Major Business
2.4.3 WuXi Biologics Life Science CDMO Product and Solutions
2.4.4 WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 WuXi Biologics Recent Developments and Future Plans
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business
2.5.3 Samsung Biologics Life Science CDMO Product and Solutions
2.5.4 Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Samsung Biologics Recent Developments and Future Plans
2.6 Siegfried
2.6.1 Siegfried Details
2.6.2 Siegfried Major Business
2.6.3 Siegfried Life Science CDMO Product and Solutions
2.6.4 Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Siegfried Recent Developments and Future Plans
2.7 Fujifilm Diosynth Biotechnologies
2.7.1 Fujifilm Diosynth Biotechnologies Details
2.7.2 Fujifilm Diosynth Biotechnologies Major Business
2.7.3 Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Solutions
2.7.4 Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
2.8 Lars Petersen
2.8.1 Lars Petersen Details
2.8.2 Lars Petersen Major Business
2.8.3 Lars Petersen Life Science CDMO Product and Solutions
2.8.4 Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lars Petersen Recent Developments and Future Plans
2.9 Recipharm
2.9.1 Recipharm Details
2.9.2 Recipharm Major Business
2.9.3 Recipharm Life Science CDMO Product and Solutions
2.9.4 Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Recipharm Recent Developments and Future Plans
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business
2.10.3 Boehringer Ingelheim Life Science CDMO Product and Solutions
2.10.4 Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Boehringer Ingelheim Recent Developments and Future Plans
2.11 MilliporeSigma
2.11.1 MilliporeSigma Details
2.11.2 MilliporeSigma Major Business
2.11.3 MilliporeSigma Life Science CDMO Product and Solutions
2.11.4 MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MilliporeSigma Recent Developments and Future Plans
2.12 Aenova Group
2.12.1 Aenova Group Details
2.12.2 Aenova Group Major Business
2.12.3 Aenova Group Life Science CDMO Product and Solutions
2.12.4 Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aenova Group Recent Developments and Future Plans
2.13 AGC Parma Chemicals
2.13.1 AGC Parma Chemicals Details
2.13.2 AGC Parma Chemicals Major Business
2.13.3 AGC Parma Chemicals Life Science CDMO Product and Solutions
2.13.4 AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 AGC Parma Chemicals Recent Developments and Future Plans
2.14 GenScript
2.14.1 GenScript Details
2.14.2 GenScript Major Business
2.14.3 GenScript Life Science CDMO Product and Solutions
2.14.4 GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GenScript Recent Developments and Future Plans
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Life Science CDMO Product and Solutions
2.15.4 Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Novartis Recent Developments and Future Plans
2.16 Sai Life Sciences
2.16.1 Sai Life Sciences Details
2.16.2 Sai Life Sciences Major Business
2.16.3 Sai Life Sciences Life Science CDMO Product and Solutions
2.16.4 Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sai Life Sciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Life Science CDMO Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Life Science CDMO by Company Revenue
3.2.2 Top 3 Life Science CDMO Players Market Share in 2023
3.2.3 Top 6 Life Science CDMO Players Market Share in 2023
3.3 Life Science CDMO Market: Overall Company Footprint Analysis
3.3.1 Life Science CDMO Market: Region Footprint
3.3.2 Life Science CDMO Market: Company Product Type Footprint
3.3.3 Life Science CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Life Science CDMO Consumption Value and Market Share by Type (2019-2024)
4.2 Global Life Science CDMO Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Life Science CDMO Consumption Value Market Share by Application (2019-2024)
5.2 Global Life Science CDMO Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Life Science CDMO Consumption Value by Type (2019-2030)
6.2 North America Life Science CDMO Consumption Value by Application (2019-2030)
6.3 North America Life Science CDMO Market Size by Country
6.3.1 North America Life Science CDMO Consumption Value by Country (2019-2030)
6.3.2 United States Life Science CDMO Market Size and Forecast (2019-2030)
6.3.3 Canada Life Science CDMO Market Size and Forecast (2019-2030)
6.3.4 Mexico Life Science CDMO Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Life Science CDMO Consumption Value by Type (2019-2030)
7.2 Europe Life Science CDMO Consumption Value by Application (2019-2030)
7.3 Europe Life Science CDMO Market Size by Country
7.3.1 Europe Life Science CDMO Consumption Value by Country (2019-2030)
7.3.2 Germany Life Science CDMO Market Size and Forecast (2019-2030)
7.3.3 France Life Science CDMO Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Life Science CDMO Market Size and Forecast (2019-2030)
7.3.5 Russia Life Science CDMO Market Size and Forecast (2019-2030)
7.3.6 Italy Life Science CDMO Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Life Science CDMO Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Life Science CDMO Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Life Science CDMO Market Size by Region
8.3.1 Asia-Pacific Life Science CDMO Consumption Value by Region (2019-2030)
8.3.2 China Life Science CDMO Market Size and Forecast (2019-2030)
8.3.3 Japan Life Science CDMO Market Size and Forecast (2019-2030)
8.3.4 South Korea Life Science CDMO Market Size and Forecast (2019-2030)
8.3.5 India Life Science CDMO Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Life Science CDMO Market Size and Forecast (2019-2030)
8.3.7 Australia Life Science CDMO Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Life Science CDMO Consumption Value by Type (2019-2030)
9.2 South America Life Science CDMO Consumption Value by Application (2019-2030)
9.3 South America Life Science CDMO Market Size by Country
9.3.1 South America Life Science CDMO Consumption Value by Country (2019-2030)
9.3.2 Brazil Life Science CDMO Market Size and Forecast (2019-2030)
9.3.3 Argentina Life Science CDMO Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Life Science CDMO Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Life Science CDMO Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Life Science CDMO Market Size by Country
10.3.1 Middle East & Africa Life Science CDMO Consumption Value by Country (2019-2030)
10.3.2 Turkey Life Science CDMO Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Life Science CDMO Market Size and Forecast (2019-2030)
10.3.4 UAE Life Science CDMO Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Life Science CDMO Market Drivers
11.2 Life Science CDMO Market Restraints
11.3 Life Science CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Life Science CDMO Industry Chain
12.2 Life Science CDMO Upstream Analysis
12.3 Life Science CDMO Midstream Analysis
12.4 Life Science CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Life Science CDMO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Life Science CDMO Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Life Science CDMO Product and Solutions
Table 8. Lonza Group Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Life Science CDMO Product and Solutions
Table 13. Thermo Fisher Scientific Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Life Science CDMO Product and Solutions
Table 18. Catalent Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Catalent Recent Developments and Future Plans
Table 20. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 21. WuXi Biologics Major Business
Table 22. WuXi Biologics Life Science CDMO Product and Solutions
Table 23. WuXi Biologics Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. WuXi Biologics Recent Developments and Future Plans
Table 25. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 26. Samsung Biologics Major Business
Table 27. Samsung Biologics Life Science CDMO Product and Solutions
Table 28. Samsung Biologics Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Samsung Biologics Recent Developments and Future Plans
Table 30. Siegfried Company Information, Head Office, and Major Competitors
Table 31. Siegfried Major Business
Table 32. Siegfried Life Science CDMO Product and Solutions
Table 33. Siegfried Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Siegfried Recent Developments and Future Plans
Table 35. Fujifilm Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 36. Fujifilm Diosynth Biotechnologies Major Business
Table 37. Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Solutions
Table 38. Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
Table 40. Lars Petersen Company Information, Head Office, and Major Competitors
Table 41. Lars Petersen Major Business
Table 42. Lars Petersen Life Science CDMO Product and Solutions
Table 43. Lars Petersen Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Lars Petersen Recent Developments and Future Plans
Table 45. Recipharm Company Information, Head Office, and Major Competitors
Table 46. Recipharm Major Business
Table 47. Recipharm Life Science CDMO Product and Solutions
Table 48. Recipharm Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Recipharm Recent Developments and Future Plans
Table 50. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 51. Boehringer Ingelheim Major Business
Table 52. Boehringer Ingelheim Life Science CDMO Product and Solutions
Table 53. Boehringer Ingelheim Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Boehringer Ingelheim Recent Developments and Future Plans
Table 55. MilliporeSigma Company Information, Head Office, and Major Competitors
Table 56. MilliporeSigma Major Business
Table 57. MilliporeSigma Life Science CDMO Product and Solutions
Table 58. MilliporeSigma Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MilliporeSigma Recent Developments and Future Plans
Table 60. Aenova Group Company Information, Head Office, and Major Competitors
Table 61. Aenova Group Major Business
Table 62. Aenova Group Life Science CDMO Product and Solutions
Table 63. Aenova Group Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aenova Group Recent Developments and Future Plans
Table 65. AGC Parma Chemicals Company Information, Head Office, and Major Competitors
Table 66. AGC Parma Chemicals Major Business
Table 67. AGC Parma Chemicals Life Science CDMO Product and Solutions
Table 68. AGC Parma Chemicals Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. AGC Parma Chemicals Recent Developments and Future Plans
Table 70. GenScript Company Information, Head Office, and Major Competitors
Table 71. GenScript Major Business
Table 72. GenScript Life Science CDMO Product and Solutions
Table 73. GenScript Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. GenScript Recent Developments and Future Plans
Table 75. Novartis Company Information, Head Office, and Major Competitors
Table 76. Novartis Major Business
Table 77. Novartis Life Science CDMO Product and Solutions
Table 78. Novartis Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Novartis Recent Developments and Future Plans
Table 80. Sai Life Sciences Company Information, Head Office, and Major Competitors
Table 81. Sai Life Sciences Major Business
Table 82. Sai Life Sciences Life Science CDMO Product and Solutions
Table 83. Sai Life Sciences Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Sai Life Sciences Recent Developments and Future Plans
Table 85. Global Life Science CDMO Revenue (USD Million) by Players (2019-2024)
Table 86. Global Life Science CDMO Revenue Share by Players (2019-2024)
Table 87. Breakdown of Life Science CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Life Science CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Life Science CDMO Players
Table 90. Life Science CDMO Market: Company Product Type Footprint
Table 91. Life Science CDMO Market: Company Product Application Footprint
Table 92. Life Science CDMO New Market Entrants and Barriers to Market Entry
Table 93. Life Science CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Life Science CDMO Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Life Science CDMO Consumption Value Share by Type (2019-2024)
Table 96. Global Life Science CDMO Consumption Value Forecast by Type (2025-2030)
Table 97. Global Life Science CDMO Consumption Value by Application (2019-2024)
Table 98. Global Life Science CDMO Consumption Value Forecast by Application (2025-2030)
Table 99. North America Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Life Science CDMO Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Life Science CDMO Raw Material
Table 130. Key Suppliers of Life Science CDMO Raw Materials
LIST OF FIGURE
s
Figure 1. Life Science CDMO Picture
Figure 2. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Life Science CDMO Consumption Value Market Share by Type in 2023
Figure 4. Active Pharmaceutical Ingredient (API) CDMO
Figure 5. Biologics CDMO
Figure 6. Finished Dosage Form (FDF) CDMO
Figure 7. Others
Figure 8. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Life Science CDMO Consumption Value Market Share by Application in 2023
Figure 10. Pharmaceutical Picture
Figure 11. Clinical Picture
Figure 12. Research Picture
Figure 13. Global Life Science CDMO Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Life Science CDMO Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Life Science CDMO Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Life Science CDMO Consumption Value Market Share by Region in 2023
Figure 18. North America Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Life Science CDMO Revenue Share by Players in 2023
Figure 24. Life Science CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Life Science CDMO Market Share in 2023
Figure 26. Global Top 6 Players Life Science CDMO Market Share in 2023
Figure 27. Global Life Science CDMO Consumption Value Share by Type (2019-2024)
Figure 28. Global Life Science CDMO Market Share Forecast by Type (2025-2030)
Figure 29. Global Life Science CDMO Consumption Value Share by Application (2019-2024)
Figure 30. Global Life Science CDMO Market Share Forecast by Application (2025-2030)
Figure 31. North America Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 41. France Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 48. China Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 51. India Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 65. Life Science CDMO Market Drivers
Figure 66. Life Science CDMO Market Restraints
Figure 67. Life Science CDMO Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Life Science CDMO in 2023
Figure 70. Manufacturing Process Analysis of Life Science CDMO
Figure 71. Life Science CDMO Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Table 1. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Life Science CDMO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Life Science CDMO Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Life Science CDMO Product and Solutions
Table 8. Lonza Group Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Life Science CDMO Product and Solutions
Table 13. Thermo Fisher Scientific Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Life Science CDMO Product and Solutions
Table 18. Catalent Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Catalent Recent Developments and Future Plans
Table 20. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 21. WuXi Biologics Major Business
Table 22. WuXi Biologics Life Science CDMO Product and Solutions
Table 23. WuXi Biologics Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. WuXi Biologics Recent Developments and Future Plans
Table 25. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 26. Samsung Biologics Major Business
Table 27. Samsung Biologics Life Science CDMO Product and Solutions
Table 28. Samsung Biologics Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Samsung Biologics Recent Developments and Future Plans
Table 30. Siegfried Company Information, Head Office, and Major Competitors
Table 31. Siegfried Major Business
Table 32. Siegfried Life Science CDMO Product and Solutions
Table 33. Siegfried Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Siegfried Recent Developments and Future Plans
Table 35. Fujifilm Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 36. Fujifilm Diosynth Biotechnologies Major Business
Table 37. Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Solutions
Table 38. Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
Table 40. Lars Petersen Company Information, Head Office, and Major Competitors
Table 41. Lars Petersen Major Business
Table 42. Lars Petersen Life Science CDMO Product and Solutions
Table 43. Lars Petersen Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Lars Petersen Recent Developments and Future Plans
Table 45. Recipharm Company Information, Head Office, and Major Competitors
Table 46. Recipharm Major Business
Table 47. Recipharm Life Science CDMO Product and Solutions
Table 48. Recipharm Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Recipharm Recent Developments and Future Plans
Table 50. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 51. Boehringer Ingelheim Major Business
Table 52. Boehringer Ingelheim Life Science CDMO Product and Solutions
Table 53. Boehringer Ingelheim Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Boehringer Ingelheim Recent Developments and Future Plans
Table 55. MilliporeSigma Company Information, Head Office, and Major Competitors
Table 56. MilliporeSigma Major Business
Table 57. MilliporeSigma Life Science CDMO Product and Solutions
Table 58. MilliporeSigma Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MilliporeSigma Recent Developments and Future Plans
Table 60. Aenova Group Company Information, Head Office, and Major Competitors
Table 61. Aenova Group Major Business
Table 62. Aenova Group Life Science CDMO Product and Solutions
Table 63. Aenova Group Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aenova Group Recent Developments and Future Plans
Table 65. AGC Parma Chemicals Company Information, Head Office, and Major Competitors
Table 66. AGC Parma Chemicals Major Business
Table 67. AGC Parma Chemicals Life Science CDMO Product and Solutions
Table 68. AGC Parma Chemicals Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. AGC Parma Chemicals Recent Developments and Future Plans
Table 70. GenScript Company Information, Head Office, and Major Competitors
Table 71. GenScript Major Business
Table 72. GenScript Life Science CDMO Product and Solutions
Table 73. GenScript Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. GenScript Recent Developments and Future Plans
Table 75. Novartis Company Information, Head Office, and Major Competitors
Table 76. Novartis Major Business
Table 77. Novartis Life Science CDMO Product and Solutions
Table 78. Novartis Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Novartis Recent Developments and Future Plans
Table 80. Sai Life Sciences Company Information, Head Office, and Major Competitors
Table 81. Sai Life Sciences Major Business
Table 82. Sai Life Sciences Life Science CDMO Product and Solutions
Table 83. Sai Life Sciences Life Science CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Sai Life Sciences Recent Developments and Future Plans
Table 85. Global Life Science CDMO Revenue (USD Million) by Players (2019-2024)
Table 86. Global Life Science CDMO Revenue Share by Players (2019-2024)
Table 87. Breakdown of Life Science CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Life Science CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Life Science CDMO Players
Table 90. Life Science CDMO Market: Company Product Type Footprint
Table 91. Life Science CDMO Market: Company Product Application Footprint
Table 92. Life Science CDMO New Market Entrants and Barriers to Market Entry
Table 93. Life Science CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Life Science CDMO Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Life Science CDMO Consumption Value Share by Type (2019-2024)
Table 96. Global Life Science CDMO Consumption Value Forecast by Type (2025-2030)
Table 97. Global Life Science CDMO Consumption Value by Application (2019-2024)
Table 98. Global Life Science CDMO Consumption Value Forecast by Application (2025-2030)
Table 99. North America Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Life Science CDMO Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Life Science CDMO Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Life Science CDMO Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Life Science CDMO Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Life Science CDMO Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Life Science CDMO Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Life Science CDMO Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Life Science CDMO Raw Material
Table 130. Key Suppliers of Life Science CDMO Raw Materials
LIST OF FIGURE
s
Figure 1. Life Science CDMO Picture
Figure 2. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Life Science CDMO Consumption Value Market Share by Type in 2023
Figure 4. Active Pharmaceutical Ingredient (API) CDMO
Figure 5. Biologics CDMO
Figure 6. Finished Dosage Form (FDF) CDMO
Figure 7. Others
Figure 8. Global Life Science CDMO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Life Science CDMO Consumption Value Market Share by Application in 2023
Figure 10. Pharmaceutical Picture
Figure 11. Clinical Picture
Figure 12. Research Picture
Figure 13. Global Life Science CDMO Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Life Science CDMO Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Life Science CDMO Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Life Science CDMO Consumption Value Market Share by Region in 2023
Figure 18. North America Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Life Science CDMO Revenue Share by Players in 2023
Figure 24. Life Science CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Life Science CDMO Market Share in 2023
Figure 26. Global Top 6 Players Life Science CDMO Market Share in 2023
Figure 27. Global Life Science CDMO Consumption Value Share by Type (2019-2024)
Figure 28. Global Life Science CDMO Market Share Forecast by Type (2025-2030)
Figure 29. Global Life Science CDMO Consumption Value Share by Application (2019-2024)
Figure 30. Global Life Science CDMO Market Share Forecast by Application (2025-2030)
Figure 31. North America Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 41. France Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 48. China Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 51. India Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Life Science CDMO Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Life Science CDMO Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Life Science CDMO Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 65. Life Science CDMO Market Drivers
Figure 66. Life Science CDMO Market Restraints
Figure 67. Life Science CDMO Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Life Science CDMO in 2023
Figure 70. Manufacturing Process Analysis of Life Science CDMO
Figure 71. Life Science CDMO Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
